JournalsHub
.online
Find My Journal
HH

Herbert C. Heien

Optum (United States) US

63
Publications
1,349
Citations
17
H-Index
22
i10-Index
2.4
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study OA
Neena S. Abraham, Sonal Singh, G. Caleb Alexander, Herbert C. Heien, Lindsey R. Haas +2 more
BMJ 2015
344
Increased Computed Tomography Utilization in the Emergency Department and Its Association with Hospital Admission OA
Fernanda Bellolio, Herbert C. Heien, Lindsey R. Sangaralingham, Molly M. Jeffery, Ronna L. Campbell +3 more
Western Journal of Emergency Medicine 2017
139
Association of Barrett's Esophagus With Type II Diabetes Mellitus: Results From a Large Population-based Case-Control Study OA
Prasad G. Iyer, Bijan J. Borah, Herbert C. Heien, Ananya Das, Gregory S. Cooper +1 more
Clinical Gastroenterology and Hepatology 2013
102
Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy
Aylin Riedel, Herbert C. Heien, Jenifer Wogen, Craig Plauschinat
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2007
79
Comparative Effectiveness and Safety of Anti–Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn’s Disease
Siddharth Singh, Herbert C. Heien, Lindsey R. Sangaralingham, Stephanie R. Schilz, Michael D. Kappelman +2 more
Clinical Gastroenterology and Hepatology 2016
68

Publications

62 total

Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011–2021 PDF

Joseph R. Herges, Rodolfo J. Galindo, Joshua J. Neumiller, Herbert C. Heien, Guillermo E. Umpierrez et al. - Diabetes Care, 2023
Cited by 26 OpenAlex

Association of Area-Level Socioeconomic Deprivation With Hypoglycemic and Hyperglycemic Crises in US Adults With Diabetes PDF

Shaheen Kurani, Herbert C. Heien, Lindsey R. Sangaralingham, Jonathan Inselman, Nilay D. Shah et al. - JAMA Network Open, 2022
Cited by 67 OpenAlex

Evolution of Clinical Complexity, Treatment Burden, Health Care Use, and Diabetes-Related Outcomes Among Commercial and Medicare Advantage Plan Beneficiaries With Diabetes in the U.S., 2006-2018. OA

Tyler J. Benning, H. Heien, R. McCoy - Diabetes Care, 2022
Cited by 4 Semantic Scholar

626 The trajectory of Multimorbidity in patients with Systemic Lupus Erythematosus in the United States OA

A. Duarte-García, Mariam Stevens, H. Heien, Gabriel Figueroa-Parra, Joseph P. Meade - Clinical Research in SLE, 2022
Cited by 0 Semantic Scholar

Comparative Risk of Serious Infections With Tumor Necrosis Factor α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases PDF

Siddharth Singh, Herbert C. Heien, Jeph Herrin, Parambir S. Dulai, Lindsey R. Sangaralingham et al. - Clinical Gastroenterology and Hepatology, 2021
Cited by 38 OpenAlex

Cost drivers of locally advanced rectal cancer treatment—An analysis of a leading healthcare insurer

F. Grass, A. Merchea, K. Mathis, N. Mishra, H. Heien - Journal of Surgical Oncology, 2021
Cited by 11 Semantic Scholar

Obesity Is Not Associated With an Increased Risk of Serious Infections in Biologic-Treated Patients With Inflammatory Bowel Diseases OA

Siddharth Singh, H. Heien, L. Sangaralingham, N. Shah, W. Sandborn - Clinical and Translational Gastroenterology, 2021
Cited by 7 Semantic Scholar

Risk of Malignancy with Vedolizumab Versus Tumor Necrosis Factor-α Antagonists in Patients with Inflammatory Bowel Diseases OA

Siddharth Singh, H. Heien, L. Sangaralingham, N. Shah, W. Sandborn - Digestive Diseases and Sciences, 2021
Cited by 3 Semantic Scholar

Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases PDF

Siddharth Singh, Herbert C. Heien, Lindsey R. Sangaralingham, Nilay D. Shah, Jennifer C. Lai et al. - Inflammatory Bowel Diseases, 2020
Cited by 36 OpenAlex

S0861 Comparative Risk of Serious Infections With Tumor Necrosis Factor-α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases OA

Siddharth Singh, H. Heien, J. Herrin, P. Dulai, L. Sangaralingham - Unknown Venue, 2020
Cited by 0 Semantic Scholar

Research Topics

Diabetes Management and Research (11) Inflammatory Bowel Disease (10) Diabetes Treatment and Management (9) Health Systems, Economic Evaluations, Quality of Life (6) Chronic Disease Management Strategies (6)

Frequent Co-Authors

NI
Nilay D. Shah
7 joint publications
LI
Lindsey R. Sangaralingham
6 joint publications
BI
Bijan J. Borah
4 joint publications
SI
Siddharth Singh
4 joint publications
PR
Prasad G. Iyer
2 joint publications
AN
Ananya Das
2 joint publications

Affiliations

Mayo Clinic
US 2024 - 2013
Minnesota State University, Mankato
US 2014 - 2014
WinnMed
US 2023 - 2017
Health Outcomes Solutions (United States)
US 2008 - 2008
University of Minnesota Rochester
US 2024 - 2024

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now